Christoph Meinert
Papers
2
Total Citations
21
H-Index
2
About
Dr. Christoph Meinert is pioneering the automation of 3D cell culture and biomaterial production, with a focus on enhancing reproducibility and throughput in tissue engineering. His key research areas include gelatin methacryloyl (GelMA)-based hydrogels, open-source technology platforms, and opto-mechatronic systems for high-throughput screening. Meinert's major contributions center on developing cost-effective, automated workflows to replace manual, time-intensive processes. His 2021 paper on an open-source platform for GelMA hydrogels (17 citations) has become a foundational resource, enabling researchers to produce tailorable, bioactive hydrogels with unprecedented reproducibility. More recently, his 2023 work on a fluorescence-based opto-mechatronic screening module (4 citations) addresses the critical need for automated, user-independent 3D cell culture solutions, overcoming limitations of traditional bioprinters. By integrating robotics, optics, and software, Meinert's innovations are democratizing access to advanced biomaterial fabrication and high-content screening. His work is particularly impactful for labs seeking to scale up drug testing and regenerative medicine studies without sacrificing experimental rigor. Through open-source designs and modular systems, Dr. Meinert is driving a paradigm shift toward reproducible, high-throughput 3D cell culture, making him a key figure in the future of biofabrication.
Research Focus
Key Achievements
Top Papers
- 1
- 2